Yeon Ok Suh on Muck Rack

Yeon Ok Suh

As seen in: Nature, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yeon Ok

Contact Yeon Ok, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors

|
By Franz J. Zemp, Hyojin Song, Taye Louie, Hongrui Liu, Yeon Ok Suh, Edna Ayerim Mandujano-Tinoco, Nicolas Collao, Joanna Pyczek, Kristofor K. Ellestad, Cini M. John, Laura K. Mah, Jahanara Rajwani, Danyel Evseev, Madison Turk, Sacha Benaoudia, Jonathan Alex, Victor Naumenko, Varsha Thoppey Manoharan, Harmony Smith, Aaron Gillmor, Hayley M. Todesco, Bo-Young Ahn, Colleen Anderson, Saif Sikdar, Tarek A. Bismar, Daniel Heng, Keith Lawson, W. Marston Linehan, Haley Pedersen, Paul Gordon, John McIntyre Verified, john Mcintyre, John MacGregor, Livia Garzia, Kathy Brodeur-Robb, Travis Ogilvie, Patrick Schöffski, Agnieszka Wozniak, Robert Holt, John Bell, Donna L. Senger, Victor A Lewis, Michael J. Monument, Omar Khan, Lou Baudrier, Pierre Billon, Vincent Gabriel, Jeff Biernaskie, Kiril Trpkov, Kevin Hay Verified, Jennifer Chan, Ramy R. Saleh, Jan Henning, Mona Shafey, A. Sorana Morrissy, Douglas J. Mahoney, Zackariah Breckenridge, Gurveer S. Gill, Kiran Narta, Louisa Guignard, Jada Curry, Jethro Langley, Mobina Kazemi Mehrabadi, Geneece N. Y. Gilbert, Ted B. Verhey, Katalin Osz, Ana Bogossian, Shahrbano Rukunuddin, Lisa DiFrancesco, Kyle Potts, Jennifer Quizi, Nicole L. Prokopishyn
| Nature Verified
Abstract Chimeric antigen receptor (CAR) T cell therapy for solid tumors is constrained by the scarcity of safe, uniformly expressed cell-surface targets. Here we identify glycoprotein NMB (GPNMB)—an MiT/TFE-family fusion-driven protein—as being highly, homogeneously and stably expressed in primary and relapsed alveolar soft-part sarcoma (ASPS) and translocation renal cell carcinoma.
Open in Who Shared Issue with article?
See all 1 licensed articles (2 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified